OpGen Inc. Files 8-K on Delisting Notice
Ticker: CFOR · Form: 8-K · Filed: Jun 3, 2024 · CIK: 1293818
| Field | Detail |
|---|---|
| Company | Opgen Inc (CFOR) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
OpGen's in hot water with the exchange, might get delisted.
AI Summary
OpGen, Inc. filed an 8-K on May 29, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Rockville, MD.
Why It Matters
This filing indicates potential issues with OpGen's continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards suggests significant financial or operational distress for the company.
Key Numbers
- 20240529 — Date of Report (Earliest event reported)
Key Players & Entities
- OpGen, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Rockville, MD (location) — Address of principal executive offices
- 001-37367 (identifier) — Commission File Number
- 06-1614015 (identifier) — I.R.S. Employer Identification Number
FAQ
What specific listing rule or standard did OpGen, Inc. fail to satisfy?
The filing states it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify which rule was violated in the provided text.
What is the reason for the potential transfer of listing mentioned in the filing?
The filing indicates a 'Transfer of Listing' as an item of information, but the specific reasons for this transfer are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated May 29, 2024.
What is OpGen, Inc.'s principal executive office address?
OpGen, Inc.'s principal executive offices are located at 9717 Key West Ave, Suite 100, Rockville, MD 20850.
What is OpGen, Inc.'s telephone number?
OpGen, Inc.'s telephone number is (240) 813-1260.
Filing Stats: 695 words · 3 min read · ~2 pages · Grade level 13.5 · Accepted 2024-06-03 16:01:21
Filing Documents
- opgeninc_8k.htm (8-K) — 29KB
- 0001829126-24-003926.txt ( ) — 198KB
- opgn-20240529.xsd (EX-101.SCH) — 3KB
- opgn-20240529_lab.xml (EX-101.LAB) — 33KB
- opgn-20240529_pre.xml (EX-101.PRE) — 22KB
- opgeninc_8k_htm.xml (XML) — 4KB
01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed in a Current Report on Form 8-K filed on May 24, 2024, OpGen, Inc. (the "Company") received an additional notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company was delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the "Form 10-Q") and was therefore not in compliance with Nasdaq Listing Rule 5250(c)(1). Following submission of the Company's plan to cure such delinquency, on May 29, 2024, the Nasdaq Hearings Panel granted the Company's request for continued listing subject to the Company filing its Form 10-Q by July 8, 2024. The Company plans to file its Form 10-Q as soon as practicable; however, no assurance can be given as to the definitive date on which such report will be filed.
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that are intended to qualify for the safe harbor from liability established thereunder. Such forward-looking statements are subject to risks and uncertainties that are often difficult to predict, are beyond the Company's control, and which may cause results to differ materially from expectations, including the risk that the Company's intention to regain compliance with Nasdaq's listing rules will not be achieved. In addition, for a further discussion of factors that could materially affect the outcome of the Company's forward-looking statements and its future results and financial condition, see "Risk Factors" in Part I, Item 1A, of the Company's Annual Report on Form 10-K for the year ended December 31, 2022 and its other reports filed with the Securities and Exchange Commission. The Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: June 3, 2024 OpGen, Inc. By: /s/ David Lazar Name: David Lazar Title: Chairman and Chief Executive Officer 2